• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

FDA finds no misconduct at trial sites for Pfizer's Lyme disease shot, Care Access says

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Oct 12, 2023 at 11:42: AM
via The U.S. health regulator did not find any misconduct at clinical sites managed by Care Access for Pfizer (PFE.N) and French partner Valneva's (VLS.PA) trial of a Lyme disease vaccine candidate, the contract research firm said on Wednesday.

article source
 




Top Bottom
Back
Quote